Controlled drug delivery
Read Online

Controlled drug delivery International Symposium of the Association for Pharmaceutical Technology (APV), Bad Homburg, 12-14 Nov., 1984 by

  • 552 Want to read
  • ·
  • 68 Currently reading

Published by Wissenschaftliche Verlagsgesellschaft in Stuttgart .
Written in English


  • Drugs -- Controlled release -- Congresses

Book details:

Edition Notes

Includes bibliographies.

Statementedited by Bernd W. Müller.
SeriesPaperback APV -- Bd. 17
ContributionsMüller, Bernd W., Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik.
LC ClassificationsRS201C64 C642 1987
The Physical Object
Pagination286 p. :
Number of Pages286
ID Numbers
Open LibraryOL21201219M
ISBN 103804708757

Download Controlled drug delivery


Controlled And Novel Drug Delivery book. Read 7 reviews from the world's largest community for readers. This book gathers together the research work of l /5. The book contains chapters that describe the relevant animal physiological and anatomical considerations alongside descriptions of current and emerging controlled release delivery systems for a variety of routes for drug delivery, and present overviews on the physical and chemical assessment of veterinary controlled release delivery : M.J. Rathbone. Since drug-loaded particles appear particularly suited for controlled release and specific site targeted release, they have been a major focus of research for new drug delivery systems. 24 Among these drug delivery systems, inorganic porous materials are emerging as a new category of host/guest systems. MCM and SBA are typical examples of. controlled drug delivery systems (patches), can also be used. These will be discussed in more depth in Chapter 6. It has to be taken into account, though, that one of the main functions of the skin as an organ is to prevent particles or compounds entering the body, rather than allowing them to be.

This book provides a comprehensive introduction to advanced drug delivery and targeting, covering their principles, current applications, and potential future developments. This edition has been updated to reflect significant trends and cutting-edge advances that .   Rev. ed. of: Sustained and controlled release drug delivery systems / edited by Joseph R. Robinson. cPages: Polymers for Controlled Drug Delivery addresses the challenges of designing macromolecules that deliver therapeutic agents that function safely and in concert with living organisms. The book primarily discusses classes of polymers and polymeric vehicles, including particulates, such as latexes, coacervates, ion-exchange resins, and liposomes, as well as non-particulate vehicles such as enteric 3/5(3). Controlled Drug Delivery Challenges and Strategies, Kinam Park, , Medical, pages. This volume discusses the challenges of creating controlled release dosage forms that will deliver new the book serve toWhiskey with a Twist, Nina Wright, , Fiction, pages. WhiskeyFile Size: KB.

  When supplying controlled drugs to a person or their representative, take reasonable steps to confirm their identity before providing the controlled drug. If intending to supply dispensed controlled drugs to a person in police custody, first check whether the custody staff have adequate arrangements and handling facilities for.   He has written fifteen publications, six presentations, and eight patents in the drug delivery and controlled release fields. KINAM PARK, PhD, is a Professor in the Department of Pharmaceutics and Showalter Distinguished Professor of Biomedical Engineering at Purdue University. controlled drug delivery million patients benefit from advanced drug delivery systems today, receiving safer and more effective doses of the medicines they need to fight a variety of human ailments, including cancer. Controlled Drug Delivery (CDD) occurs when a .   This book will describe current research on drug delivery systems that encompass four broad categories, namely: routes of delivery, delivery vehicles, payload, and targeting strategies. Where appropriate delivery vehicles and relevant release of specific agents in any of these categories in clinical application will be : Emmanuel Opara.